JP2008509143A - 気道疾患の処置のためのプレコナリルを含む薬学的処方物 - Google Patents

気道疾患の処置のためのプレコナリルを含む薬学的処方物 Download PDF

Info

Publication number
JP2008509143A
JP2008509143A JP2007524916A JP2007524916A JP2008509143A JP 2008509143 A JP2008509143 A JP 2008509143A JP 2007524916 A JP2007524916 A JP 2007524916A JP 2007524916 A JP2007524916 A JP 2007524916A JP 2008509143 A JP2008509143 A JP 2008509143A
Authority
JP
Japan
Prior art keywords
medicament
dispersion
pressure gas
carrier
high pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007524916A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509143A5 (enExample
Inventor
セオドア エル． リスゴー，
ポール ティー． メデイロス，
キース アンソニー エルウェイ，
トーマス ジェイ． ヒギンズ，
リチャード アール． ローバー，
ブルース エー． マルコム，
エレイン ラドワンスキー，
ヘリベルト ダブリュー． シュタウディンガー，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of JP2008509143A publication Critical patent/JP2008509143A/ja
Publication of JP2008509143A5 publication Critical patent/JP2008509143A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2007524916A 2004-08-04 2005-08-03 気道疾患の処置のためのプレコナリルを含む薬学的処方物 Pending JP2008509143A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59861804P 2004-08-04 2004-08-04
PCT/US2005/027428 WO2006017505A2 (en) 2004-08-04 2005-08-03 Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008192563A Division JP2008297311A (ja) 2004-08-04 2008-07-25 気道疾患の処置のためのプレコナリルを含む薬学的処方物

Publications (2)

Publication Number Publication Date
JP2008509143A true JP2008509143A (ja) 2008-03-27
JP2008509143A5 JP2008509143A5 (enExample) 2008-09-25

Family

ID=35583475

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007524916A Pending JP2008509143A (ja) 2004-08-04 2005-08-03 気道疾患の処置のためのプレコナリルを含む薬学的処方物
JP2008192563A Pending JP2008297311A (ja) 2004-08-04 2008-07-25 気道疾患の処置のためのプレコナリルを含む薬学的処方物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008192563A Pending JP2008297311A (ja) 2004-08-04 2008-07-25 気道疾患の処置のためのプレコナリルを含む薬学的処方物

Country Status (6)

Country Link
US (1) US20060030550A1 (enExample)
EP (1) EP1819329A2 (enExample)
JP (2) JP2008509143A (enExample)
CA (1) CA2575932A1 (enExample)
MX (1) MX2007001561A (enExample)
WO (1) WO2006017505A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170035919A (ko) * 2014-06-25 2017-03-31 옵티노즈 에이에스 코 투여
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7902177B2 (en) 2005-05-02 2011-03-08 Wandzel Richard A Treatment of congestion using steroids and adrenergics
EP1981475A2 (en) * 2006-02-09 2008-10-22 Schering Corporation Pharmaceutical formulations
CA2641616A1 (en) * 2006-02-09 2007-08-23 Schering Corporation Pharmaceutical formulations
JP2009526064A (ja) * 2006-02-09 2009-07-16 シェーリング コーポレイション 薬学的調合物
CN1907293B (zh) * 2006-08-22 2012-07-04 蔡海德 一种治疗肺炎的组合药物及其制备方法
US20080069874A1 (en) * 2006-09-15 2008-03-20 Auriga Laboratories, Inc. Kits for Prevention and Treatment of Rhinitis
WO2009079078A1 (en) 2007-12-14 2009-06-25 Labogroup S.A.S. Delivering aerosolizable food products
TW201016215A (en) * 2008-07-17 2010-05-01 Schering Corp Compositions and uses of antiviral active pharmaceutical agents
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US10149823B2 (en) 2013-04-30 2018-12-11 Otitopic Inc. Dry powder formulations and methods of use
EP4241771A3 (en) 2013-11-08 2023-11-22 Antivirus Therapeutics Methods and compositions for treating sepsis
US10139321B2 (en) * 2016-07-29 2018-11-27 Alpha-Tec Systems, Inc. Mucolytic tablet for a sample collection device
CN107669635A (zh) * 2016-09-30 2018-02-09 青岛大学 一种用于治疗呼吸系统疾病的气雾剂及其制备方法
CN107513071B (zh) * 2017-08-30 2019-06-04 新乡医学院 一种多功能鬼臼毒素衍生物及其制备方法和应用
CN115919780A (zh) 2017-09-22 2023-04-07 维克图拉公司 含有硬脂酸镁的干粉组合物
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
CN111166719A (zh) * 2019-12-31 2020-05-19 郑州都灵兽药科技有限公司 一种泰拉霉素肠溶颗粒的制备方法
GB202103803D0 (en) * 2021-03-18 2021-05-05 Queens Univ Of Belfast Anti-viral therapy
CN114177176B (zh) * 2021-12-04 2022-07-12 中国农业科学院兰州兽医研究所 化合物盐酸赛庚啶在制备预防或治疗非洲猪瘟药物中的应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003020271A1 (en) * 2001-08-29 2003-03-13 Viropharma Incorporated Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents
JP2003516314A (ja) * 1999-09-17 2003-05-13 スミスクライン・ビーチャム・コーポレイション ライノウイルス感染症におけるｃｓａｉｄの使用
WO2003065988A2 (en) * 2002-02-04 2003-08-14 Pharmacia Corporation A combination for treating cold and cough
WO2003068222A1 (en) * 2002-02-14 2003-08-21 Viropharma Incorporated Methods of reducing rhinovirus contagion and related compositions
WO2004018025A1 (en) * 2002-08-23 2004-03-04 Schering Corporation Pharmaceutical compositions
JP2004517848A (ja) * 2000-12-18 2004-06-17 バイオウタ サイエンティフィック マネジメント プロプライエタリー リミテッド 抗ウイルス剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1618005A1 (de) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
DE3106995A1 (de) * 1981-02-25 1982-08-19 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung von guajocalglycerinether
WO1985003707A1 (en) * 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
US4731447A (en) * 1985-05-13 1988-03-15 Schering Corporation Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof
SK140493A3 (en) * 1991-06-10 1994-10-05 Schering Corp Non-chlorofluorocarbon aerosol formulations
JP2600644B2 (ja) * 1991-08-16 1997-04-16 藤沢薬品工業株式会社 チアゾリルベンゾフラン誘導体
US5352707A (en) * 1992-03-26 1994-10-04 Harbor Branch Oceanographic Institution, Inc. Method for treating airway congestion
US5270324A (en) * 1992-04-10 1993-12-14 Merck Frosst Canada, Inc. Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
US5349068A (en) * 1992-04-15 1994-09-20 Sterling Winthrop Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US5472964A (en) * 1992-12-22 1995-12-05 Merck Frosst Canada, Inc. Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
US6068832A (en) * 1996-08-29 2000-05-30 Schering Corporation Chlorofluorocarbon-free mometasone furoate aerosol formulations
US5894179A (en) * 1997-12-17 1999-04-13 Emerson Electric Co. Motor with strategically placed connector block
NZ519797A (en) * 2000-02-03 2005-05-27 Schering Corp Treating allergic and inflammatory conditions
NZ523659A (en) * 2000-07-18 2006-01-27 Smithkline Beecham Corp Use of IL-8 receptor antagonists in the treatment of virus infections
DE60119534T2 (de) * 2000-07-28 2007-05-10 Immupharm Aps Verwendung von hydroxyethylrutosiden zur behandlung von erkältungssymptomen, symptomen der allergischen rhinitis und atemwegsinfektionen
PE20020507A1 (es) * 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
GB0123951D0 (en) * 2001-10-05 2001-11-28 Glaxo Group Ltd Therapies for treating respiratory diseases
JP2006508178A (ja) * 2002-09-10 2006-03-09 マイクロバイオティクス，インコーポレーテッド 抗菌性ピラゾールカルボン酸ヒドラジド

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003516314A (ja) * 1999-09-17 2003-05-13 スミスクライン・ビーチャム・コーポレイション ライノウイルス感染症におけるｃｓａｉｄの使用
JP2004517848A (ja) * 2000-12-18 2004-06-17 バイオウタ サイエンティフィック マネジメント プロプライエタリー リミテッド 抗ウイルス剤
WO2003020271A1 (en) * 2001-08-29 2003-03-13 Viropharma Incorporated Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents
WO2003065988A2 (en) * 2002-02-04 2003-08-14 Pharmacia Corporation A combination for treating cold and cough
WO2003068222A1 (en) * 2002-02-14 2003-08-21 Viropharma Incorporated Methods of reducing rhinovirus contagion and related compositions
WO2004018025A1 (en) * 2002-08-23 2004-03-04 Schering Corporation Pharmaceutical compositions

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
KR20170035919A (ko) * 2014-06-25 2017-03-31 옵티노즈 에이에스 코 투여
JP2017520364A (ja) * 2014-06-25 2017-07-27 オプティノーズ アズ 経鼻投与
JP2020179191A (ja) * 2014-06-25 2020-11-05 オプティノーズ アズ 経鼻投与
JP7090124B2 (ja) 2014-06-25 2022-06-23 オプティノーズ アズ 経鼻投与
KR102458964B1 (ko) 2014-06-25 2022-10-25 옵티노즈, 인크. 코 투여

Also Published As

Publication number Publication date
MX2007001561A (es) 2007-04-16
WO2006017505A2 (en) 2006-02-16
EP1819329A2 (en) 2007-08-22
CA2575932A1 (en) 2006-02-16
JP2008297311A (ja) 2008-12-11
US20060030550A1 (en) 2006-02-09
WO2006017505A3 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
JP2008297311A (ja) 気道疾患の処置のためのプレコナリルを含む薬学的処方物
JP2008509143A5 (enExample)
JP2009526063A (ja) 医薬製剤
DK2486942T3 (en) COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
US20070202050A1 (en) Pharmaceutical Formulations
US8758816B2 (en) Compositions comprising azelastine and methods of use thereof
US20100144610A1 (en) Pharmaceutical formulations
US20040235807A1 (en) Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
US20060110449A1 (en) Pharmaceutical composition
CN101883562A (zh) 包含西替利嗪以及非β-2-肾上腺素受体激动剂、β-2-肾上腺素受体激动剂或消炎药的组合物及其用于治疗呼吸疾病的用途
JP5362151B2 (ja) Ｐｇｄ２拮抗剤及びヒスタミン拮抗剤からなるアレルギー性鼻炎治療用医薬
JP2004529108A (ja) Ｒ−サルメテロールおよびプロピオン酸フルチカゾンを含んでなる医薬製剤
HK1159518A (en) Compositions comprising azelastine and methods of use thereof

Legal Events

Date Code Title Description
A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20080724

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080725

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080725

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110809

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111108

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111115

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120222